Back to top
more

Thermo Fisher Scientific (TMO)

(Delayed Data from NYSE)

$536.87 USD

536.87
1,636,065

+5.01 (0.94%)

Updated Jul 10, 2024 04:00 PM ET

After-Market: $536.96 +0.09 (0.02%) 7:28 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 39% (152 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Has Thermo Fisher Scientific (TMO) Outpaced Other Medical Stocks This Year?

Is (TMO) Outperforming Other Medical Stocks This Year?

The Zacks Analyst Blog Highlights: Eli Lilly, Mitsubishi UFJ, Thermo Fisher, Oracle and Ecolab

The Zacks Analyst Blog Highlights: Eli Lilly, Mitsubishi UFJ, Thermo Fisher, Oracle and Ecolab

Mark Vickery headshot

Top Analyst Reports for Eli Lilly, Mitsubishi UFJ & Thermo Fisher

Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Mitsubishi UFJ Financial Group, Inc. (MUFG) and Thermo Fisher Scientific Inc. (TMO).

Thermo Fisher (TMO) Rides on New Buyouts and APAC Strength

We are upbeat about Thermo Fisher's (TMO) recent buyout of Advanced Bioprocessing business, which will add complementary cell culture products to the company's bioproduction suit.

Has Thermo Fisher Scientific (TMO) Outpaced Other Medical Stocks This Year?

Is (TMO) Outperforming Other Medical Stocks This Year?

Zacks.com featured highlights include: Intel, Thermo Fisher, Marcus, Anthem and ArcBest

Zacks.com featured highlights include: Intel, Thermo Fisher, Marcus, Anthem and ArcBest

The Zacks Analyst Blog Highlights: Alphabet, Bank of America, Tesla, Thermo Fisher and Carnival

The Zacks Analyst Blog Highlights: Alphabet, Bank of America, Tesla, Thermo Fisher and Carnival

Sweta Killa headshot

5 Solid Dividend Growth Stocks for Your Portfolio

Dividend-paying securities are the major source of consistent income for investors when returns from the equity market are at risk.

Mark Vickery headshot

Top Analyst Reports for Alphabet, Bank of America & Tesla

Today's Research Daily features new research reports on 16 major stocks, including Alphabet (GOOGL), Bank of America (BAC) and Tesla (TSLA).

The Zacks Analyst Blog Highlights: Johnson & Johnson, Thermo Fisher, Goldman Sachs, Oracle and Accenture

The Zacks Analyst Blog Highlights: Johnson & Johnson, Thermo Fisher, Goldman Sachs, Oracle and Accenture

Here's Why You Should Buy Thermo Fisher (TMO) Stock Now

Thermo Fisher (TMO) gains on strength in all end markets. It witnesses consistent growth in the Asia-Pacific and emerging markets.

Mark Vickery headshot

Top Analyst Reports for Johnson & Johnson, Thermo Fisher & Goldman Sachs

Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Thermo Fisher (TMO) and Goldman Sachs (GS).

Thermo Fisher (TMO) Rides on APAC Strength Despite Cost Woes

Thermo Fisher (TMO) is registering a sturdy global footprint with strong growth seen in Asia-Pacific including China.

Is Thermo Fisher Scientific (TMO) Outperforming Other Medical Stocks This Year?

Is (TMO) Outperforming Other Medical Stocks This Year?

Pacific Biosciences Offers Insights on Aedes aegypti Genome

Pacific Biosciences (PACB) uses its flagship Single Molecule, Real-Time technology to sequence the highest quality genome assembly for the Aedes aegypti mosquito.

Pacific Biosciences (PACB) Reports Q3 Loss, Revenues Fall Y/Y

Pacific Biosciences (PACB) is getting acquired by Illumina (ILMN) by mid-2019.

Illumina (ILMN) Inks $1.2B Deal to Buy Pacific Biosciences

Illumina (ILMN) taking out on its peer, in the $1.2-billion acquisition deal, will further strengthen the position of the former in the genomics market.

Zacks.com highlights: Dick's Sporting Goods, Microsoft, Matson, Thermo Fisher Scientific and Progressive

Zacks.com highlights: Dick's Sporting Goods, Microsoft, Matson, Thermo Fisher Scientific and Progressive

Sweta Killa headshot

5 Attractive Dividend Growth Stocks on Sale

Here are some attractive stock picks that are the major source of consistent income for investors when returns from the equity market are at risk.

The Zacks Analyst Blog Highlights: McDonald's, Thermo Fisher, Caterpillar, CSX and Celgene

The Zacks Analyst Blog Highlights: McDonald's, Thermo Fisher, Caterpillar, CSX and Celgene

Mark Vickery headshot

Top Research Reports for McDonald's, Thermo Fisher & Caterpillar

Today's Research Daily features new research reports on 16 major stocks, including McDonald's (MCD), Thermo Fisher (TMO) and Caterpillar (CAT).

Thermo Fisher (TMO) Beats on Q3 Earnings, Ups '18 Guidance

Thermo Fisher (TMO) raises its 2018 revenue view, banking on a solid third-quarter operational performance, partially offset by a less favorable foreign exchange.

Thermo Fisher Scientific (TMO) Beats Q3 Earnings and Revenue Estimates

Thermo Fisher (TMO) delivered earnings and revenue surprises of 2.75% and 3.93%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

Medical Products Q3 Earnings on Oct 24: BSX, ALGN & More

Long-term potential of the Medical Products industry appears promising at the moment amid certain short-term geopolitical insecurities.

Is a Surprise Coming for Thermo Fisher Scientific (TMO) This Earnings Season?

Thermo Fisher Scientific (TMO) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.